Research and Markets has announced the addition of the "Neuropathic Pain Drugs Price Analysis and Strategies - 2016" report to their offering.
The latest research Neuropathic Pain Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Neuropathic Pain market.
The research answers the following questions:
Neuropathic Pain Treatment Options - Identify key drugs marketed and prescribed for Neuropathic Pain in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
Neuropathic Pain Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Neuropathic Pain
Market Positioning - Identify how drugs are clinically and commercially positioned in the global Neuropathic Pain market
Neuropathic Pain Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Neuropathic Pain in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
Neuropathic Pain New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan
For more information about this report visit http://www.researchandmarkets.com/research/h925s8/neuropathic_pain
View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005344/en/Business Wire
Last updated on: 04/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.